132 related articles for article (PubMed ID: 37660735)
1. Comparing ceftolozane/tazobactam versus piperacillin/tazobactam for the initial empiric therapy of urinary tract infections: A retrospective comparative study.
Nakagawa T; Shigehara K; Shinzawa R; Yaegashi H; Kawaguchi S; Nohara T; Izumi K; Mizokami A
J Infect Chemother; 2024 Jan; 30(1):12-16. PubMed ID: 37660735
[TBL] [Abstract][Full Text] [Related]
2. Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: A cost-utility model focusing on gram-negative bacteria.
Chen GJ; Pan SC; Foo J; Morel C; Chen WT; Wang JT
J Microbiol Immunol Infect; 2019 Oct; 52(5):807-815. PubMed ID: 31029529
[TBL] [Abstract][Full Text] [Related]
3. Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial.
Kaye KS; Belley A; Barth P; Lahlou O; Knechtle P; Motta P; Velicitat P
JAMA; 2022 Oct; 328(13):1304-1314. PubMed ID: 36194218
[TBL] [Abstract][Full Text] [Related]
4. [Clinical effects of piperacillin and tazobactam/piperacillin on Haemophilus influenzae lower respiratory tract infection in pediatric patients].
Sudo F; Ishiwada N; Hoshino T; Fukasawa C; Inami Y; Hishiki H; Takeda N; Kurosaki T; Kohno Y
Kansenshogaku Zasshi; 2005 Sep; 79(9):637-43. PubMed ID: 16248372
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial prophylaxis for transurethral resection of bladder tumor: A retrospective comparison of preoperative single-dose administration of piperacillin and tazobactam/piperacillin.
Murakami M; Kiyota H; Kasai K; Bando S; Kira S; Koide H; Yamada H; Kimura T; Egawa S
J Infect Chemother; 2018 Dec; 24(12):954-957. PubMed ID: 30193786
[TBL] [Abstract][Full Text] [Related]
6. [Laboratory and clinical studies on tazobactam/piperacillin in the field of pediatrics].
Kuno K; Ogawa A; Hayakawa F; Miyajima Y; Takahashi H; Okumura A; Kato T; Itomi K
Jpn J Antibiot; 1998 Jun; 51(6):395-406. PubMed ID: 9755829
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of cefmetazole versus carbapenems and piperacillin/tazobactam as initial therapy for bacteremic acute cholangitis: A retrospective study.
Aoto K; Inose R; Kosaka T; Shikata K; Muraki Y
J Infect Chemother; 2024 Mar; 30(3):213-218. PubMed ID: 37832824
[TBL] [Abstract][Full Text] [Related]
8. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
[TBL] [Abstract][Full Text] [Related]
9. Tazobactam/ceftolozane and tobramycin combination therapy in extensively drug-resistant Pseudomonas aeruginosa infections in severe burn injury: a case report.
Ibe Y; Kakizaki R; Inamura H; Ishigo T; Fujiya Y; Inoue H; Uemura S; Fujii S; Takahashi S; Narimatsu E; Fukudo M
J Pharm Health Care Sci; 2023 Aug; 9(1):25. PubMed ID: 37550794
[TBL] [Abstract][Full Text] [Related]
10. [A comparative study of tazobactam/piperacillin and piperacillin in chronic respiratory tract infections].
Oizumi K; Kawahara M; Kawaguchi S; Sigematsu H; Tanaka F; Sano N; Saito A; Hiraga Y; Ohmichi M; Inoue H
Jpn J Antibiot; 1995 Apr; 48(4):482-513. PubMed ID: 7783314
[TBL] [Abstract][Full Text] [Related]
11. Ceftolozane-Tazobactam Pharmacokinetics in the Abdominal Tissue of Patients Undergoing Lower Gastrointestinal Surgery: Dosing Considerations Based on Site-Specific Pharmacodynamic Target Attainment.
Yoshimura K; Ohge H; Ikawa K; Uegami S; Watadani Y; Shigemoto N; Hirano T; Kitagawa H; Kaiki Y; Morikawa N; Takahashi S
Infect Dis Ther; 2023 Jan; 12(1):193-207. PubMed ID: 36418742
[TBL] [Abstract][Full Text] [Related]
12. An update on the management of urinary tract infections in the era of antimicrobial resistance.
Bader MS; Loeb M; Brooks AA
Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic and clinical evaluation of tazobactam/piperacillin in the pediatric field].
Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
Jpn J Antibiot; 1998 May; 51(5):325-45. PubMed ID: 9693966
[TBL] [Abstract][Full Text] [Related]
14. Meropenem versus piperacillin/tazobactam for febrile neutropenia in pediatric patients: efficacy of piperacillin/tazobactam as a 1-h drip infusion four times a day.
Kobayashi R; Sano H; Matsushima S; Hori D; Yanagi M; Kodama K; Suzuki D; Kobayashi K
Int J Hematol; 2021 Mar; 113(3):430-435. PubMed ID: 33170417
[TBL] [Abstract][Full Text] [Related]
15. [A comparative study of tazobactam/piperacillin and piperacillin in bacterial pneumonia].
Oizumi K; Ohno T; Kawahara M; Kawaguchi S; Saisho M; Mitutake Y; Saito A; Tomizawa M; Koike T; Takebe K
Jpn J Antibiot; 1995 Apr; 48(4):449-81. PubMed ID: 7783313
[TBL] [Abstract][Full Text] [Related]
16. Incidence of acute kidney injury after teicoplanin- or vancomycin- and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis.
Sazanami K; Inose R; Yagi T; Dote S; Horiuchi N; Kobayashi Y; Muraki Y
J Infect Chemother; 2021 Dec; 27(12):1723-1728. PubMed ID: 34446352
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic, bacteriological and clinical evaluation of tazobactam/piperacillin in pediatrics].
Iwai N; Nakamura H; Miyazu M
Jpn J Antibiot; 1998 May; 51(5):346-61. PubMed ID: 9693967
[TBL] [Abstract][Full Text] [Related]
18. [Concentration of tazobactam/piperacillin in the cerebrospinal fluid of patients with Haemophilus influenzae type B meningitis].
Fukasawa C; Hoshino T; Kutsuna S; Sawada K; Sato H; Ishiwada N
Kansenshogaku Zasshi; 2013 Sep; 87(5):590-5. PubMed ID: 24195168
[TBL] [Abstract][Full Text] [Related]
19. A Meta-Analysis on Clinical Outcomes of Ceftolozane versus Piperacillin in Combination with Tazobactam in Patients with Complicated Urinary Tract Infections.
Saeed MW; Gillani SW; Mahmood RK; Vippadapu P; Hussain MW; Rathore HA
Biomed Res Int; 2022; 2022():1639114. PubMed ID: 35978637
[TBL] [Abstract][Full Text] [Related]
20. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents.
Bader MS; Loeb M; Leto D; Brooks AA
Postgrad Med; 2020 Apr; 132(3):234-250. PubMed ID: 31608743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
